ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,563Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 1206

$523K Total Retail Price of All Prescriptions

Rank: 146 out of 1206

435 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,817 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 533 429 1 1
LISINOPRIL 462 354 2 4
OMEPRAZOLE 451 354 3 3
FUROSEMIDE 399 304 4 5
METFORMIN HCL 308 227 5 10
LEVOTHYROXINE SODIUM 304 224 6 2
TRAMADOL HCL 284 200 7 17
WARFARIN SODIUM 240 206 8 8
POTASSIUM CHLORIDE 234 181 9 12
METOPROLOL TARTRATE 213 159 10 9
MELOXICAM 212 167 11 35
RANITIDINE HCL 211 165 12 23
AMLODIPINE BESYLATE 208 203 13 6
GABAPENTIN 183 120 14 18
PAROXETINE HCL 166 124 15 53
HYDROCODONE-ACETAMINOPHEN 155 82 S3 16 7
RISPERIDONE 151 118 17 74
GLIMEPIRIDE 143 97 18 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 134 19 27
ATENOLOL 132 132 20 14
SERTRALINE HCL 119 82 21 22
METOPROLOL SUCCINATE 118 98 22 15
HYDROCHLOROTHIAZIDE 116 113 23 11
TAMSULOSIN HCL 116 112 23 26
POLYETHYLENE GLYCOL 3350 114 102 25 31
ALENDRONATE SODIUM 113 91 26 19
NAMENDA 111 86 27 36
VENLAFAXINE HCL ER 109 74 28 89
ATORVASTATIN CALCIUM 107 95 29 13
CITALOPRAM HBR 81 67 30 16
FLUTICASONE PROPIONATE 80 61 31 42
LANTUS 79 64 32 38
CLONIDINE HCL 77 75 33 88
ISOSORBIDE MONONITRATE ER 74 74 34 40
TRAZODONE HCL 73 61 35 37
DIOVAN 72 67 36 57
ZOLPIDEM TARTRATE 69 68 37 25
FLUOXETINE HCL 68 62 38 52
CARVEDILOL 67 56 39 32
SPIRONOLACTONE 67 44 39 41
DILTIAZEM 24HR CD 66 52 41 67
FENTANYL 65 28 S2 42 51
PREDNISONE 63 43 43 28
CRESTOR 60 37 44 30
CARBIDOPA-LEVODOPA 59 39 45 70
AMLODIPINE BESYLATE-BENAZEPRIL 58 47 46 76
ADVAIR DISKUS 58 37 46 55
ENALAPRIL MALEATE 57 57 48 45
LOVASTATIN 56 56 49 44
MIRTAZAPINE 54 30 50 50
ACTOS 54 32 50 98
AMITRIPTYLINE HCL 53 46 R 52 59
CYMBALTA 53 43 52 63
PROAIR HFA 51 40 54 49
DONEPEZIL HCL 51 51 54 29
CLOPIDOGREL 50 50 56 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.